Parker Geoffrey M.
SEC CIK 1491874 · EDGAR
BoughtSold
Most active insiders at PRGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Parker Geoffrey M. | Dir | $106.3K | — |
| 2 | Winterman Matthew John | EVP, Supply, Ops, Strategy | — | — |
| 3 | Egan Kevin Francis | Dir | — | — |
| 4 | Samuelson Jonas | Dir | — | — |
| 5 | Lennox Abigail | EVP, CSO | — | — |
| 6 | Atkinson Charles | EVP, GC, Sec | — | — |
| 7 | Ball David | EVP, CBDO | — | — |
| 8 | Khoury Roberto | EVP, Pres of CSCI | — | — |
| 9 | Lockwood-Taylor Patrick | Former CEO, Dir | — | — |
| 10 | Brown Julia M | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 16:19 | 2026-09-11 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $13.66 | +1,263 | 34.5K | +4% | +$17.3K |
| D | 2026-09-15 16:19 | 2026-09-11 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $13.66 | -607 | 33.9K | -2% | -$8,292 |
| D | 2026-06-16 16:54 | 2026-06-12 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $10.99 | +976 | 33.7K | +3% | +$10.7K |
| D | 2026-06-16 16:54 | 2026-06-12 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $10.99 | -469 | 33.2K | -1% | -$5,154 |
| D | 2026-05-15 16:59 | 2026-05-14 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $10.84 | +7,305 | 36.2K | +25% | +$79.2K |
| D | 2026-05-15 16:59 | 2026-05-14 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $10.84 | -3,507 | 32.7K | -10% | -$38.0K |
| D | 2026-02-04 | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale | $1.76 | -24.0K | 1.25M | -2% | -$42.2K |
| I | 2025-11-14 | 2025-11-12 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $14.18 | +7,500 | 17.4K | +76% | +$106.3K |
| 2025-10-23 | 2025-10-21 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale | $1.26 | -36.7K | 1.28M | -3% | -$46.3K | |
| AI | 2025-08-20 | 2025-08-18 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $22.97 | +4,375 | 9,875 | +80% | +$100.5K |
| 2025-08-19 | 2025-08-18 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $22.97 | +4,375 | 33.3K | +15% | +$100.5K | |
| D | 2025-05-16 | 2025-05-14 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $26.01 | -4,754 | 28.9K | -14% | -$123.7K |
| D | 2025-05-16 | 2025-05-14 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $26.01 | +9,904 | 33.7K | +42% | +$257.6K |
| 2025-05-14 | 2025-05-12 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $27.10 | +3,500 | 23.8K | +17% | +$94.8K | |
| 2025-02-05 | 2025-02-03 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale | $1.73 | -4,361 | 1.30M | -0.3% | -$7,545 | |
| D | 2025-01-28 | 2025-01-24 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | A - Grant | $0.00 | +173.9K | 1.31M | +15% | $0 |
| 2024-10-23 | 2024-10-21 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | F - Tax | $2.84 | -36.4K | 1.13M | -3% | -$103.4K | |
| 2024-05-20 | 2024-05-16 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | A - Grant | $2.90 | +344.8K | 1.16M | +42% | +$1.00M | |
| D | 2024-05-16 | 2024-05-15 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $30.22 | +8,764 | 24.5K | +56% | +$264.8K |
| D | 2024-05-16 | 2024-05-15 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $30.22 | -4,207 | 20.3K | -17% | -$127.1K |
| 2024-03-06 | 2024-01-30 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | P - Purchase | $3.60 | +190 | 819.6K | +0.0% | +$684 | |
| D | 2024-01-31 | 2024-01-25 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | A - Grant | $0.00 | +29.4K | 819.4K | +4% | $0 |
| DM | 2023-10-17 | 2023-10-16 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | A - Grant | $0.00 | +790.0K | 400.0K | New | $0 |
| I | 2023-06-14 | 2023-06-13 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $33.06 | +10.0K | 25.9K | +63% | +$330.6K |
| D | 2023-05-19 | 2023-05-17 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $32.86 | +7,778 | 19.4K | +67% | +$255.6K |
| D | 2023-05-19 | 2023-05-17 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $32.86 | -3,734 | 15.7K | -19% | -$122.7K |
| I | 2023-03-07 | 2023-03-06 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $38.05 | +5,000 | 15.9K | +46% | +$190.2K |
| D | 2022-05-19 | 2022-05-17 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | M - OptEx | $38.57 | +6,599 | 14.8K | +80% | +$254.5K |
| D | 2022-05-19 | 2022-05-17 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | F - Tax | $38.57 | -3,168 | 11.7K | -21% | -$122.2K |
| I | 2021-12-17 | 2021-12-16 | PRGO | PERRIGO Co plc | Parker Geoffrey M. | Dir | P - Purchase | $36.85 | +5,000 | 10.9K | +85% | +$184.2K |
Purchase Sale Sale after option exercise All abbreviations